Neurofilament Light Chain Levels in Serum and Cerebrospinal Fluid Do Not Correlate with Survival Times in Patients with Prion Disease
Prion diseases, including Creutzfeldt–Jakob disease (CJD), are deadly neurodegenerative disorders characterized by the buildup of abnormal prion proteins in the brain. This accumulation disrupts neuronal functions, leading to the rapid onset of psychiatric symptoms, ataxia, and cognitive decline. Th...
Saved in:
Main Authors: | Mika Shimamura, Kong Weijie, Toshiaki Nonaka, Koki Kosami, Ryusuke Ae, Koji Fujita, Taiki Matsubayashi, Tadashi Tsukamoto, Nobuo Sanjo, Katsuya Satoh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/15/1/8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unmet needs of biochemical biomarkers for human prion diseases
by: Peter Hermann, et al.
Published: (2024-12-01) -
Novel method for classification of prion diseases by detecting PrPres signal patterns from formalin-fixed paraffin-embedded samples
by: Sachiko Koyama, et al.
Published: (2024-12-01) -
Exploring CJD incidence trends: insights from Slovakia
by: Pavol Skacik, et al.
Published: (2024-12-01) -
β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer’s and Parkinson’s disease
by: Bing Xu, et al.
Published: (2025-02-01) -
A systemic analysis of Creutzfeldt Jakob disease cases in Asia
by: Urwah Rasheed, et al.
Published: (2024-12-01)